Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. ... is being tested as a treatment for chronic obstructive pulmonary disease in former smokers.

The conditions of participants ranged from moderate to severe, or stages 2–4 as assessed by the medically recognized scale of the Global Initiative for Chronic Obstructive Lung Disease (GOLD). During ...

Introduction Fibrotic interstitial lung diseases (F-ILD) are severe and often progressive lung disorders that frequently lead to respiratory failure, with patients experiencing high symptom burdens, ...

Pope Francis, history’s first pontiff from Latin America, has died.The 88-year-old religious leader battled chronic lung disease throughout his life, ending in over a monthlong hospitalization ...

To find out if your lung disease is restrictive or obstructive. Restrictive means less air will get into your lungs. Obstructive means less air will get out of your lungs. Peak flow monitor. This test ...

Background Pulmonary microvasculature alterations are implicated in emphysema pathogenesis, but the association between pulmonary microvascular blood volume (PMBV) and emphysema has not been directly ...

Aerwave Medical raised $12 million in a recently closed deal to advance a new therapy for chronic obstructive pulmonary disease, which completed its first human trials last week.

The aim of this study was to perform a quantitative analysis to assess the relevance of the auscultation site on the chest wall in classifying restrictive lung diseases versus the healthy class.

The study revealed that higher long-term relative humidity (RH) exposure was associated with a lower risk of restrictive lung disease, offering potential protective effects. For example, a 4-year ...

Central conducting lymphatic anomaly with pulmonary lymphatic dysplasia causes restrictive lung disease and chronic pleural effusion. Mudit Gupta, MD [email protected] ... connections and ...

There are three primary types of chronic lung disease. Restrictive lung disease makes it difficult to inhale air. Obstructive lung diseases result in difficulty in exhaling air from your lungs.

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for certain adults with poorly controlled chronic obstructive pulmonary disease (COPD).